BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Jun 15, 2017 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10 Total Citation Count
- Dec 02, 2015 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0165,282 USE OF BETA-NICOTINAMIDE MONONUCLEOTIDE IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING ARTERIOSCLEROSIS AND CARDIO-CEREBROVASCULAR DISEASES, AND DRUGS CONTAINING THE SAMEDec 11, 15Jun 15, 17[A61K]
2016/0340,377 METHOD FOR PURIFYING OXIDIZED FORM OF BETA-NICOTINAMIDE ADENINE DINUCLEOTIDEDec 04, 15Nov 24, 16[C07H]
2016/0340,378 METHOD FOR PURIFYING OXIDIZED FORM OF BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATEDec 04, 15Nov 24, 16[C07H]
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0080,011 USE OF NADH AND NMN IN PREPARATION OF DRUGS OR HEALTH-CARE PRODUCTS FOR TREATING PARKINSON'S DISEASEAbandonedDec 03, 15Mar 23, 17[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.